A

Ascendis Pharma A/S
D

ASND

136.110
USD
-1.56
(-1.13%)
مغلق
حجم التداول
0
الربح لكل سهم
-8
العائد الربحي
-
P/E
-17
حجم السوق
8,139,350,642
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AAL
    0.220
    (1.32%)
    16.870 USD
    AMP
    AMP
    7.05
    (1.34%)
    532.49 USD
    B
    BFS
    0.300
    (0.78%)
    38.650 USD
    C
    CF
    1.130
    (1.35%)
    84.960 USD
    ETN
    ETN
    2.48
    (0.74%)
    338.04 USD
    L
    LSXMA
    0
    (0%)
    0.000000 USD
    O
    OCFC
    0.020
    (0.11%)
    17.805 USD
    T
    TKR
    0.930
    (1.31%)
    71.690 USD
    المزيد
الأخبار

العنوان: Ascendis Pharma A/S

القطاع: Healthcare
الصناعة: Biotechnology
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.